ERBB2 and cancer: The cytotoxicity of DTX, DTX-L, and DTX-ECL was assessed on HER2 positive cancer cell lines, HT-29 cells and SK-BR-3 cells, and HER2 negative cancer cell line, MDA-MB-231 cells (Figure 4A) [35,36].